Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-036-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 10
- Absorption rate - inhalation (%):
- 100
Additional information
Absorption
The physicochemical data suggest that the substance, betaines, C12-16 (even numbered) -alkyldimethyl, would be expected to be absorbed after oral exposure and therefore be systemically available. This was corroborated by the acute oral, sub-chronic studies and developmental toxicity study where some toxicity was evident. However, the data overall suggest that the substances tested were of relatively low to moderate toxicity despite their systemic availability after oral exposure.
Absorption by the dermal route might be expected to be low as reflected in the LD50 result from the acute toxicity study. However, in a study on two Zwitterionic surfactants (Buckset al, 1993) there was significant adsorption into the upper layers of the stratum corneum. It was suggested that such adsorption might not make the test substance readily available for absorption. In another study, using excised hairless mouse skin, cetyl betaine was partitioned into the skin but was only slowly transferred to the receptor phase - approximately 1.3% of the applied dose absorbed within 24 hours (study reviewed in CIR, 2018). In the same CIR publication, another study using human skin in vivo also suggested that the test substance (lauryl betaine) was adsorbed mostly into the stratum corneum. Overall, the evidence suggests that dermal penetration of betaine, cetyl betaine and lauryl betaine was exceptionally low (CIR,2018). As a conservative estimate it is likely that less than 10% dermal absorption (i.e. dose available systemically) would be considered as appropriate for use in risk assessments.
Information on the absorption and elimination of betaine has been described from a double-blind crossover study in humans (reviewed in CIR, 2018). Each subject ingested betaine in doses of 1, 3, and 6 g mixed with 150 mL orange juice. The doses were ingested 7 days apart following a 12-hour overnight fast. Blood samples for serum betaine concentration measurement were drawn just before receiving the betaine dose, at 20-minute intervals during the first 3 hours and then at 4, 7, and 24 hours post-dosing. Urine samples were collected before dosing and during the 24-hour follow-up period. Within 2 hours, a dose-dependent increase in serum betaine concentration was observed. Absorption and elimination of betaine were dose dependent, with urinary excretion of betaine increasing with betaine dose. Only a small proportion of the ingested betaine was excreted in urine with only 3.2%, 4.3%, and 7.4% of the 1, 3, and 6 g doses accounted for, respectively.
The physicochemical data for the substance suggest that it is unlikely that acute inhalation exposure (not expected to present an exposure risk) would result in adverse toxicity considering the relatively low toxicity evident in the acute or repeat dose studies presented.
Distribution
No data were found that specifically dealt with body, organ, or tissue distribution of the substance or associated read-across substances. However, the evidence suggests that there was some absorption after oral exposure which would indicate a moderate degree of oral absorption. It is likely, given the physicochemical nature of the substance, that there would be significant distribution in the GI tract and the liver and kidneys (as the main organs of metabolism and systemic excretion). There was no evidence to suggest bioaccumulation.
Metabolism
It is expected, from both the physicochemical and toxicity data, that metabolism (of the absorbed dose) would be mostly via the liver and secondarily the kidneys (e.g. effects on the kidneys were seen after sub-chronic exposure). It is also likely that significant metabolism/degradation would occur within the GI tract.
Excretion
Given the physicochemical properties of the substance, the nature of the effects seen in the repeat dose toxicity studies and probable limited bioaccumulation, it is predicted that excretion, (of parent and metabolites) would mostly be via the urine and faeces.
References
CIR (2018) |
Safety Assessment of Alkyl Betaines as Used in Cosmetics. International Journal of Toxicology, Vol. 37(Supplement 1) 28S-46S. |
Bucks DA, Hostynek JJ, Hinz RS and Guy RH (1993) |
Uptake of two Zwitterionic surfactants into human skin in vivo. Toxicology and Applied Pharmacology, 120, 224-227.
|
US EPA (2010) |
U.S. Environmental Protection Agency: Hazard Characterization Document; Screening level hazard characterization, Fatty Nitrogen-Derived Amphoterics Category, Subcategory I: Acyl amino propanaminium amphoterics.
|
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.